The Nordics are known to provide exceptional opportunities for Real-World-Evidence studies due to the rich data.
The countries however have rather different availability of data.
In this webinar we will have an opportunity learn about the opportunities and limitations in Finland, including a case-study followed by a discussion of how Finland compares with Sweden.
Agenda:
- Overview to the Finnish RWE opportunity (Lisse-Lotte)
- What data is available?
- What types of studies are feasible?
- The administrative process to access data.
- Case-study (Jussi)
- Comparing Swedish and Finnish Data (Lisse-Lotte and Mattias)
Lisse-Lotte Hermansson
Love working with exceptionally tech savvy individuals. Successful track record in business development and +20 years of global life science experience with EFPIA HTA WG and Orphan WG 2007-11 and chaired MedTech EU (EDMA) HTA and CDx WG 2011-16. Worked with due diligence, HEOR and health policy globally. M.Sc Econ. (Helsinki School of Economics) and M.Sc HE (Karolinska) Ph.D cand on hold in health care effectiveness.
Jussi Salmi
Adjunct Professor Jussi Salmi has 20 years of experience in the field of Artificial Intelligence in Medicine. He has published about 20 scientific articles in topics such as Data Science, Genomics, Health Informatics and Proteomics. He is working as a data Scientist at BCB Medical